A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.

Scientists are supercharging patients' own immune cells to try to fight HIV without today's drugs. A small study is giving a ...

On the occasion of World AIDS Day on 1 December 2024, the International Antiviral (formerly AIDS) Society-USA (IAS-USA) has published new international guidelines for the treatment and prevention of ...

Three people were able to suppress the virus for months without their usual treatment regimen.

Engineered CAR‑T cells suppressed HIV off medication in two people — promising but early. Larger trials are needed.

Researchers conducted a retrospective study to evaluate changes in blood pressure and various metabolic parameters among patients with acute HIV infection who initiated either EFV- or DTG-based ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment ...

By Deena Beasley May 11 (Reuters) - Re-engineering an HIV patient's own immune cells to find and destroy the virus succeeded ...

Children who acquire HIV in utero face a lifetime of antiretroviral therapy to keep the virus at bay, but a new study finds that children may be able to pause those treatments. Multinational research ...

HIV treatment has delivered life-altering advantages. Antiretroviral therapy has led to reduced mortality and improved life expectancy for people living with HIV. Nearly 41 million people were living ...

A new injectable solution that self-assembles into a gel under the right conditions could help manage HIV unlike any currently available methods, researchers have found. The gel releases a steady dose ...